Parallel Advisors LLC Sells 3,233 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Parallel Advisors LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.4% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 31,303 shares of the healthcare conglomerate's stock after selling 3,233 shares during the period. Parallel Advisors LLC's holdings in UnitedHealth Group were worth $16,395,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Capital & Planning LLC raised its stake in shares of UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock valued at $248,000 after buying an additional 79 shares during the period. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after buying an additional 28,231 shares during the period. Union Bancaire Privee UBP SA bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at $27,233,000. Revolve Wealth Partners LLC grew its stake in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares in the last quarter. Finally, Hanson & Doremus Investment Management grew its stake in UnitedHealth Group by 112.9% in the 4th quarter. Hanson & Doremus Investment Management now owns 892 shares of the healthcare conglomerate's stock valued at $451,000 after buying an additional 473 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In other news, CFO John F. Rex acquired 17,175 shares of the business's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John H. Noseworthy acquired 300 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $312.16 per share, with a total value of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares of the company's stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Up 1.0%

NYSE:UNH traded up $3.02 during trading hours on Monday, reaching $304.93. 11,862,787 shares of the company traded hands, compared to its average volume of 10,783,936. The business's 50-day moving average price is $430.87 and its two-hundred day moving average price is $492.75. The stock has a market capitalization of $276.61 billion, a P/E ratio of 19.67, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Barclays reduced their target price on UnitedHealth Group to $350.00 and set an "overweight" rating for the company in a research report on Monday. Deutsche Bank Aktiengesellschaft reduced their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Wall Street Zen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, HSBC reissued a "reduce" rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average price target of $439.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.